Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Total Current Liabilities: 2021-2024

Historic Total Current Liabilities for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $38.0 million.

  • Prime Medicine's Total Current Liabilities fell 7.55% to $35.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year decrease of 7.55%. This contributed to the annual value of $38.0 million for FY2024, which is 32.72% down from last year.
  • According to the latest figures from FY2024, Prime Medicine's Total Current Liabilities is $38.0 million, which was down 32.72% from $56.4 million recorded in FY2023.
  • Prime Medicine's 5-year Total Current Liabilities high stood at $58.0 million for FY2021, and its period low was $26.7 million during FY2022.
  • Over the past 3 years, Prime Medicine's median Total Current Liabilities value was $38.0 million (recorded in 2024), while the average stood at $40.4 million.
  • In the last 5 years, Prime Medicine's Total Current Liabilities tumbled by 53.93% in 2022 and then surged by 111.21% in 2023.
  • Yearly analysis of 4 years shows Prime Medicine's Total Current Liabilities stood at $58.0 million in 2021, then slumped by 53.93% to $26.7 million in 2022, then spiked by 111.21% to $56.4 million in 2023, then tumbled by 32.72% to $38.0 million in 2024.